Barbara Renga Selected Research

Therapeutics

1/2014	In vivo administration of ritonavir worsens intestinal damage caused by cyclooxygease inhibitors.
5/2013	Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice.
1/2013	Role of nuclear receptors in lipid dysfunction and obesity-related diseases.
1/2012	Mechanistic role of p38 MAPK in gastric cancer dissemination in a rodent model peritoneal metastasis.
1/2012	Discovery that theonellasterol a marine sponge sterol is a highly selective FXR antagonist that protects against liver injury in cholestasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Barbara Renga Research Topics

Disease

15	Inflammation (Inflammations) 01/2014 - 12/2004
11	Colitis 11/2013 - 10/2006
6	Cholestasis 01/2015 - 09/2005
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2013 - 11/2009
4	Dyslipidemias (Dyslipidemia) 02/2014 - 10/2010
4	Neoplasms (Cancer) 12/2013 - 10/2007
4	Stomach Neoplasms (Stomach Cancer) 12/2013 - 01/2012
4	Atherosclerosis 05/2013 - 10/2010
4	Pain (Aches) 01/2013 - 01/2006
4	Liver Cirrhosis (Hepatic Cirrhosis) 02/2008 - 11/2004
3	Portal Hypertension 01/2015 - 09/2005
3	Fibrosis (Cirrhosis) 01/2015 - 09/2005
3	Rheumatoid Arthritis 12/2013 - 12/2004
3	Arthritis (Polyarthritis) 12/2013 - 12/2004
3	Crohn Disease (Crohn's Disease) 01/2011 - 11/2009
2	Obesity 02/2014 - 01/2013
2	Infections 01/2014 - 10/2012
2	Carcinoma (Carcinomatosis) 01/2013 - 01/2012
2	Peritoneal Neoplasms 01/2013 - 01/2012
2	Hemorrhage 01/2013 - 12/2004
2	Neoplasm Metastasis (Metastasis) 01/2012 - 01/2012
2	Liver Diseases (Liver Disease) 01/2012 - 07/2006
2	Heart Failure 10/2007 - 04/2006
1	Aneuploidy (Aneuploid) 06/2018
1	Hyperhomocysteinemia 05/2015
1	Glucose Intolerance 05/2015
1	Pruritus (Itching) 01/2015
1	Peritoneal Diseases 12/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2013
1	HIV Infections (HIV Infection) 05/2013
1	Coronary Disease (Coronary Heart Disease) 05/2013
1	Body Weight (Weight, Body) 01/2013
1	Weight Gain 01/2013

Drug/Important Bio-Agent (IBA)

13	LigandsIBA 01/2015 - 11/2004
10	Bile Acids and Salts (Bile Acids)IBA 01/2015 - 07/2006
9	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2013 - 11/2004
8	Messenger RNA (mRNA)IBA 01/2014 - 11/2004
4	Ritonavir (Norvir)FDA Link 01/2014 - 10/2010
4	CytokinesIBA 12/2013 - 06/2009
4	LipidsIBA 01/2013 - 07/2006
3	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2015 - 10/2005
3	Protease Inhibitors (Protease Inhibitor)IBA 01/2014 - 01/2012
3	Chemokine CCL5IBA 12/2013 - 10/2011
3	ChemokinesIBA 12/2013 - 10/2011
3	CollagenIBA 12/2013 - 11/2004
3	Apolipoproteins E (ApoE)IBA 05/2013 - 10/2010
3	SteroidsIBA 01/2013 - 11/2009
3	AcidsIBA 08/2011 - 10/2006
3	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 10/2006 - 09/2005
3	obeticholic acidIBA 09/2005 - 11/2004
2	HomocysteineIBA 05/2015 - 02/2008
2	Dinoprostone (PGE2)FDA Link 01/2014 - 12/2004
2	Naproxen (Naprosyn)FDA LinkGeneric 01/2014 - 12/2004
2	Pregnane X ReceptorIBA 12/2013 - 10/2011
2	cholan-2,3,24-tryl-2,3,24-trisulfateIBA 12/2013 - 07/2011
2	Maraviroc FDA Link 12/2013 - 05/2013
2	Cadherins (E-Cadherin)IBA 12/2013 - 01/2013
2	Pharmaceutical PreparationsIBA 05/2013 - 01/2012
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2013 - 12/2004
2	Glucose (Dextrose)FDA LinkGeneric 01/2013 - 03/2010
2	Analgesics (Analgesic Drugs)IBA 01/2013 - 06/2010
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2012 - 10/2005
2	Rifaximin (L 105)FDA Link 10/2011 - 12/2010
2	Dextran SulfateIBA 08/2011 - 11/2009
2	Interleukin-6 (Interleukin 6)IBA 01/2011 - 12/2004
2	AnthracyclinesIBA 10/2007 - 04/2006
2	Epirubicin (Ellence)FDA LinkGeneric 10/2007 - 04/2006
2	sodium bisulfide (NaHS)IBA 01/2006 - 09/2005
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2006 - 09/2005
2	Metalloproteases (Metalloproteinases)IBA 08/2005 - 11/2004
1	DNA (Deoxyribonucleic Acid)IBA 06/2018
1	Ethanol (Ethyl Alcohol)IBA 05/2015
1	isothiocyanic acidIBA 01/2015
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2015
1	Betulinic AcidIBA 01/2015
1	6-ethyl-3,7-dihydroxycholan-24-olIBA 01/2015
1	Endothelin-1 (Endothelin 1)IBA 01/2015
1	Alkaline PhosphataseIBA 01/2015
1	BAR502IBA 01/2015
1	Integrin alpha1beta1IBA 01/2014
1	AntibodiesIBA 12/2013
1	Lymphotoxin-alpha (Lymphotoxin)IBA 12/2013
1	Interleukin-10 ReceptorsIBA 12/2013
1	Proto-Oncogene Proteins c-metIBA 12/2013
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 12/2013
1	ChromatinIBA 11/2013
1	GlucocorticoidsIBA 11/2013
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2013
1	Methionine (L-Methionine)FDA Link 01/2013
1	Estrogen ReceptorsIBA 01/2013
1	Peptides (Polypeptides)IBA 01/2013
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2013
1	gorgosterolIBA 04/2012
1	farnesoid X-activated receptorIBA 04/2012
1	Cisplatin (Platino)FDA LinkGeneric 01/2012
1	Mitogen-Activated Protein KinasesIBA 01/2012

Therapy/Procedure

5	Therapeutics 01/2014 - 01/2012
2	Highly Active Antiretroviral Therapy (HAART) 01/2014 - 01/2012
2	Ligation 01/2012 - 10/2005
1	Intradermal Injections 01/2015